Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integrated analysis of two pivotal trials.

@article{Sperling2011EfficacyAS,
  title={Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integrated analysis of two pivotal trials.},
  author={Herbert Sperling and Marc M Gittelman and Christiane Norenberg and Ernst Ulbrich and Silke Ewald},
  journal={The journal of sexual medicine},
  year={2011},
  volume={8 1},
  pages={261-71}
}
INTRODUCTION Men with erectile dysfunction (ED) are typically older and have one or more underlying cardiovascular conditions. AIM To determine the efficacy and safety of a new orodispersible tablet (ODT) formulation of vardenafil for the treatment of ED, and whether age, or the presence of underlying conditions affects treatment outcomes. METHODS This is an integrated analysis of data from two phase III, double-blind, multicenter, randomized, parallel-group, placebo-controlled studies that… CONTINUE READING